Laurus Labs


Laurus Labs is an Indian pharmaceutical company headquartered in Hyderabad. It is involved in the research and development of active pharmaceutical ingredients for anti-retrovirals and hepatitis C drugs. It claims to be the world's largest third party API supplier for anti-retrovirals. The company also makes Dolutegravir/lamivudine/tenofovir, a medication for HIV/AIDS, and hydroxychloroquine tablets, which are used to treat certain types of malaria.
In March 2020, Laurus Labs received USFDA approval to market hydroxychloroquine sulfate tablets. The company announced that it would supply hydroxychloroquine to its US partner Rising Pharma for clinical trials of preventive treatment of COVID-19.